Allulose and Glycemic Response - Blood Glucose Control

Allulose Suppresses Postprandial Glycemic Response

One of the most clinically significant findings about allulose is its ability to acutely suppress the glycemic response to co-ingested carbohydrates.

Mechanism of Action

Allulose reduces postprandial blood glucose elevation through at least three mechanisms:

1. Competitive inhibition of carbohydrate digestion: Allulose acts as a weak inhibitor of α-glucosidase and α-amylase in the small intestine, modestly slowing the rate at which starch and disaccharides are broken down into absorbable monosaccharides.

2. Enhanced hepatic glucose uptake: Allulose promotes glucokinase translocation in the liver, increasing the liver's capacity to take up and store glucose from the portal circulation after a meal.

3. Delayed gastric emptying: Some evidence suggests allulose modestly slows gastric emptying, contributing to a more gradual appearance of glucose in the bloodstream.

Key Clinical Studies

Study 1: Iida et al. (2008) — Journal of Nutritional Science and Vitaminology

• Design: Single-blind crossover, 20 healthy subjects
• Intervention: 7.5g allulose + 75g maltodextrin vs. 75g maltodextrin alone
• Key finding: Allulose co-ingestion reduced postprandial glucose AUC by approximately 16% and insulin AUC by approximately 20%

Study 2: Hayashi et al. (2010) — Bioscience, Biotechnology, and Biochemistry

• Design: Randomized crossover, borderline-diabetic subjects
• Intervention: 5g allulose + standardized meal
• Key finding: Significant attenuation of postprandial glucose peak, with the effect more pronounced in subjects with impaired glucose tolerance

Study 3: Franchi et al. (2021) — Nutrients

• Design: Systematic review and meta-analysis
• Key finding: Consistent evidence across 6 RCTs that allulose (5-10g) reduces postprandial glucose excursion when ingested with carbohydrates

Clinical Significance

The glucose-moderating effect of allulose is particularly relevant for:

• Type 2 diabetes management: As an adjunct to dietary carbohydrate management
• Prediabetes: Reducing postprandial glucose spikes that contribute to disease progression
• General metabolic health: Lowering glycemic variability independent of diabetes status

Regulatory Recognition

Japan's Consumer Affairs Agency has approved Food for Specified Health Uses (FOSHU) claims for allulose-containing products, recognizing its ability to "suppress the elevation of blood glucose levels after meals."

In South Korea, the Ministry of Food and Drug Safety (MFDS) has similarly recognized allulose's postprandial blood glucose-lowering effect.